Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

AstraZeneca offers no comment after report saying CEO staying

Published 07/14/2017, 03:17 PM
Updated 07/14/2017, 03:20 PM
© Reuters. Pascal Soriot leaves after appearing at a commons science committee hearing at Portcullis House in London
TEVA
-
AZN
-
TEVA
-

LONDON (Reuters) - Anglo-Swedish pharmaceutical firm AstraZeneca (L:AZN) declined to comment on speculation about the future of its chief executive Pascal Soriot on Friday, after a report quoted Bloomberg news agency saying he would stay in his post.

The StreetInsider.com, citing Bloomberg, said Soriot was currently planning to stay for the foreseeable future.

When asked about the report, an AstraZeneca spokeswoman declined to comment, saying the firm had a policy of not responding to market speculation or rumors.

AstraZeneca has repeatedly declined to comment on Wednesday's Israeli media report saying Soriot was in talks to join Israel's Teva Pharmaceutical (NYSE:TEVA) Industries (TA:TEVA). Uncertainty over his future has hit AstraZeneca's shares.

© Reuters. Pascal Soriot leaves after appearing at a commons science committee hearing at Portcullis House in London

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.